3-AMINO-5-CHLOROPYRIDINE-2-CARBOXYLIC ACID HCL, 95.0%, 1g

4'-(Bromomethyl)-[1,1'-biphenyl]-4-carbonitrile, 100mg

(m-tolylsulfonyl)proline, 95.0%, 250mg

4-Ethynyl-2-fluorobenzonitrile, 98%, 100mg

4-Chloro-2-(methylsulfonyl)pyrimidine, 95.0%, 1g

1,1-DIMETHOXYCYCLOPENTANE, 96%, 10g

2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-amine hydrochloride, 95.0%, 5g

(R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide, 99%, 100mg

Benzoic acid benzyl ester, min. 99%, for synthesis, 250 ml, glass packaging

2-Hydroxy-1-(2-hydroxy-4-sulfo-1-naphthylazo)-3-naphthoic Acid (1:100 diluted with K2SO4)1g

TERT-BUTYL 2-OXA-8-AZASPIRO[4.5]DECANE-8-CARBOXYLATE, 95.0%, 1g

Dimethyl({[(3S)-pyrrolidin-3-yl]methyl})amine dihydrochloride, 97%, 100mg

Diethylenetriamine, min. 98%, for synthesis, 2.5 L, glass packaging